DNLI
Price
$15.47
Change
+$0.60 (+4.03%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.12B
19 days until earnings call
GPCR
Price
$23.69
Change
+$0.37 (+1.59%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.32B
14 days until earnings call
Ad is loading...

DNLI vs GPCR

Header iconDNLI vs GPCR Comparison
Open Charts DNLI vs GPCRBanner chart's image
Denali Therapeutics
Price$15.47
Change+$0.60 (+4.03%)
Volume$33.51K
Capitalization2.12B
Structure Therapeutics
Price$23.69
Change+$0.37 (+1.59%)
Volume$23.59K
Capitalization1.32B
DNLI vs GPCR Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. GPCR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and GPCR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (DNLI: $14.87 vs. GPCR: $23.32)
Brand notoriety: DNLI and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 102% vs. GPCR: 76%
Market capitalization -- DNLI: $2.12B vs. GPCR: $1.32B
DNLI [@Biotechnology] is valued at $2.12B. GPCR’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 4 bearish.
  • GPCR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than GPCR.

Price Growth

DNLI (@Biotechnology) experienced а +18.49% price change this week, while GPCR (@Biotechnology) price change was +25.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

GPCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.12B) has a higher market cap than GPCR($1.32B). GPCR YTD gains are higher at: -14.012 vs. DNLI (-27.036). GPCR has higher annual earnings (EBITDA): -157.24M vs. DNLI (-492.89M). GPCR has more cash in the bank: 884M vs. DNLI (832M). GPCR has less debt than DNLI: GPCR (3.86M) vs DNLI (48.7M). DNLI (0) and GPCR (0) have equivalent revenues.
DNLIGPCRDNLI / GPCR
Capitalization2.12B1.32B161%
EBITDA-492.89M-157.24M313%
Gain YTD-27.036-14.012193%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M884M94%
Total Debt48.7M3.86M1,261%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIGPCR
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDVIX5.300.07
+1.34%
Royce Dividend Value Invmt
PIIFX26.95N/A
N/A
Pioneer International Equity A
MGRTX42.71N/A
N/A
MFS International Growth R3
IRPSX10.35N/A
N/A
VY® T. Rowe Price Equity Income S
FSLZX40.52N/A
N/A
Fidelity Advisor Stock Selec Mid Cp Z

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+1.85%
BEAM - DNLI
59%
Loosely correlated
+3.87%
RCKT - DNLI
57%
Loosely correlated
+2.44%
NTLA - DNLI
56%
Loosely correlated
-2.65%
ARWR - DNLI
56%
Loosely correlated
+5.26%
RGNX - DNLI
56%
Loosely correlated
+13.43%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with AFMD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then AFMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+1.22%
AFMD - GPCR
45%
Loosely correlated
+4.24%
DNLI - GPCR
43%
Loosely correlated
+1.85%
CKPT - GPCR
43%
Loosely correlated
N/A
VKTX - GPCR
42%
Loosely correlated
+1.22%
OLMA - GPCR
41%
Loosely correlated
+1.01%
More